The F.D.A. authorizes AstraZeneca drug to protect people with weak immune systems.
The antibody drug, Evusheld, was found to be strongly effective in preventing Covid in a clinical trial that enrolled mostly those at high risk.
Full Article
The F.D.A. authorizes AstraZeneca drug to protect people with weak immune systems.
NYTimes.com
0 shares
2 views
You might like
Related news coverage
New COVID-19 antibody drug OK'd to protect most vulnerable
WASHINGTON (AP) — Federal health officials on Wednesday authorized a new COVID-19 antibody drug for people with serious health..
SeattlePI.com
U.S. FDA authorizes use of AstraZeneca COVID-19 antibody cocktail
The U.S. Food and Drug Administration on Wednesday authorized the use of AstraZeneca's antibody cocktail to prevent COVID-19..
Upworthy